Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun;226(6):401-409.
doi: 10.1192/bjp.2025.38. Epub 2025 Jun 20.

Trajectories and dimensional phenotypes of depressive symptoms throughout pregnancy and postpartum in relation to prior premenstrual symptoms

Affiliations

Trajectories and dimensional phenotypes of depressive symptoms throughout pregnancy and postpartum in relation to prior premenstrual symptoms

Ella Schleimann-Jensen et al. Br J Psychiatry. 2025 Jun.

Abstract

Background: Sensitivity to ovarian hormone fluctuations can lead to mental distress during the luteal phase of the menstrual cycle, such as in premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD), and also during pregnancy and postpartum, as in perinatal depression (PND).

Aims: In two cohorts, we investigated the relationship between history of PMS/PMDD and PND symptoms. We also examined how premenstrual symptoms are associated with perinatal symptom trajectories and dimensional phenotypes of PND symptoms, which remains unidentified.

Method: From early pregnancy until 6 months postpartum, participants of two large longitudinal cohorts were followed using the Edinburgh Postnatal Depression Scale (EPDS). Premenstrual symptoms were self-reported retrospectively.

Results: Both pre-pregnancy PMS and PMDD were associated with higher EPDS scores across pregnancy and postpartum, even after adjustment for confounders. The odds of developing PND were higher among those reporting PMS and PMDD, ranging up to 1.68 (95% CI 1.25-2.29) (6-13 weeks postpartum) and 3.05 (95% CI 2.26-4.10) (late pregnancy) respectively for PMS and PMDD, throughout the perinatal period. Premenstrual symptomatology was associated more with certain PND trajectories based on the time of occurrence and persistence of symptoms. However, PND symptom severity did not differ depending on premenstrual symptomatology in any trajectory. Prior PMS/PMDD was associated with underlying dimensions of symptom constructs of PND, including severe and moderate symptoms of depressed mood, anxiety and anhedonia.

Conclusions: Women with a history of PMS/PMDD require coordinated care by psychiatrists, other mental health clinicians, midwives and gynaecologists during pregnancy as well as postpartum.

Keywords: Reproductive psychiatry; ovarian hormones; perinatal depression; premenstrual disorder; women.

PubMed Disclaimer

Conflict of interest statement

I.S.-P. has occasionally served on advisory boards or acted as invited speaker at scientific meetings for Asarina Pharma, Bayer Health Care, Gedeon Richter, Peptonics, Shire/Takeda, Sandoz and Lundbeck A/S. These organisations were not involved in the design, conduct or reporting of the present research. E.C. is a member of the BJPsych editorial board and did not take part in the review or decision-making process of this paper.

Figures

Fig. 1
Fig. 1
Study design and perinatal depression (PND) symptom severity in relation to premenstrual symptomatology over time. (a) The study design of the BASIC and Mom2B studies showing the time points for completion of the Edinburgh Postnatal Depression Scale (EPDS); (b1) and (c1) group differences on continuous EPDS scores at all time points during pregnancy and postpartum between those with no premenstrual syndrome (No PMS), with premenstrual syndrome (PMS) and with premenstrual dysphoric disorder (PMDD) (BASIC)/severe PMS (Mom2B) for the BASIC and Mom2B cohorts respectively; (b2) and (c2) mean EPDS scores over all time points during pregnancy and postpartum by group: no PMS, PMS and PMDD (BASIC)/severe PMS (Mom2B) for the BASIC and Mom2B cohorts respectively. Shaded areas indicate 95% confidence intervals. Statistical significance was set at P < 0.05. ****P ≤ 0.0001.
Fig. 2
Fig. 2
Dimensional phenotypes of perinatal depression (PND) symptoms and their association with premenstrual symptomatology over time. (a1) and (b1) 3D visualisation of the dimensional phenotypes of PND symptoms and severity for the BASIC and Mom2B cohorts respectively; (a2) and (b2) the proportions of the dimensional phenotypes of PND symptoms over time grouped by no premenstrual syndrome (No PMS), premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD) (BASIC)/severe PMS (Mom2B) for the BASIC and Mom2B cohorts respectively.
Fig. 3
Fig. 3
Proportions of perinatal depression (PND) severity over time in relation to premenstrual symptomatology. The distribution of PND severity categories during pregnancy and postpartum in (a) the BASIC cohort and (b) the Mom2B cohort. The plots are grouped by no premenstrual syndrome (No PMS), premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD) (BASIC)/severe PMS (Mom2B) for the BASIC and Mom2B cohorts respectively. PND severity was defined in terms of total score on the Edinburgh Postnatal Depression Scale: none (no PND), 0–9; mild to moderate, 10–15; moderate to severe, 16–21; and very severe, 22–30.
Fig. 4
Fig. 4
Symptom severity by perinatal depression (PND) trajectory in relation to premenstrual symptomatology. Mean Edinburgh Postnatal Depression Scale (EPDS) score plots of PND trajectories based on onset and persistence of symptoms. The trajectories are: gestational PND (EPDS ≥ 12 sometime during pregnancy); postpartum PND (EPDS ≥ 12 sometime postpartum); and persistent PND (EPDS ≥ 12 during both pregnancy and postpartum); trajectories are grouped on no premenstrual syndrome (No PMS), premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD) (BASIC)/severe PMS (Mom2B) for the BASIC (a1)–(a3) and Mom2B cohorts (b1)–(b3) respectively. The data points indicate mean values and the lines 95% confidence intervals. *P < 0.05.

Similar articles

References

    1. Epperson CN, Steiner M, Hartlage SA, Eriksson E, Schmidt PJ, Jones I, et al. Premenstrual dysphoric disorder: evidence for a new category for DSM-5. Am J Psychiatry 2012; 169: 465–75. - PMC - PubMed
    1. Pearlstein T, Steiner M. Premenstrual dysphoric disorder: burden of illness and treatment update. J Psychiatry Neurosci 2008; 33: 291–301. - PMC - PubMed
    1. Wikman A, Sacher J, Bixo M, Hirschberg AL, Kopp Kallner H, Epperson CN, et al. Prevalence and correlates of current suicidal ideation in women with premenstrual dysphoric disorder. BMC Women’s Health 2022; 22: 35. - PMC - PubMed
    1. Dennerstein L, Lehert P, Heinemann K. Global epidemiological study of variation of premenstrual symptoms with age and sociodemographic factors. Menopause Int 2011; 17: 96–101. - PubMed
    1. Yonkers KA, Simoni MK. Premenstrual disorders. Am J Obstetr Gynecol 2018; 218: 68–74. - PubMed